Kolinpharma S.p.A. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was EUR 12.48 million compared to EUR 9.32 million a year ago. Revenue was EUR 13.35 million compared to EUR 9.4 million a year ago.

Net income was EUR 0.636968 million compared to EUR 0.642372 million a year ago.